Healthcare burden of probable and proven invasive mucormycosis: a multi-centre cost-of-illness analysis of patients treated in tertiary care hospitals between 2003 and 2016.
J Hosp Infect
; 101(3): 339-346, 2019 Mar.
Article
in En
| MEDLINE
| ID: mdl-30423409
Key words
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
Database:
MEDLINE
Main subject:
Cost of Illness
/
Invasive Fungal Infections
/
Mucormycosis
Type of study:
Health_economic_evaluation
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Child
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Hosp Infect
Year:
2019
Document type:
Article